Efficacy and safety of a single dose pentamidine (7mg/kg) for patients with cutaneous leishmaniasis caused by L. guyanensis: a pilot study

Efficacy and safety of a single dose pentamidine (7mg/kg) for patients with cutaneous leishmaniasis caused by L. guyanensis: a pilot study

Abstract: BACKGROUND: There have been few studies on pentamidine in the Americas; and there is no consensus regarding the dose that should be applied. OBJECTIVES: To evaluate the use of pentamidine in a single dose to treat cutaneous leishmaniasis. METHODS: Clinical trial of phase II pilot study...

Full description

Bibliographic Details
Main Authors: Ellen Priscilla Nunes Gadelha, Sinésio Talhari, Jorge Augusto de Oliveira Guerra, Leandro Ourives Neves, Carolina Talhari, Bernardo Gontijo, Roberto Moreira da Silva Junior, Anette Chrusciak Talhari
Format: Article
Language:English
Published: Sociedade Brasileira de Dermatologia 2015-12-01
Series:Anais Brasileiros de Dermatologia
Subjects:
Leishmaniasis
Cutaneous Leishmaniasis
Pentamidine
Online Access:http://www.scielo.br/pdf/abd/v90n6/0365-0596-abd-90-06-0807.pdf

Internet

http://www.scielo.br/pdf/abd/v90n6/0365-0596-abd-90-06-0807.pdf

Similar Items